文献速递胸部CT

非小细胞肺癌转移性淋巴结的影像学结外侵犯:预后价值与诊断效能

Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance.
PubMed 文献 · AJR Am J Roentgenol · 2023-05-31

回顾性纳入382例临床N1或N2期非小细胞肺癌患者,两位胸部放射科医师评估分期胸部CT上影像学结外侵犯(无、可能/ probable、明确)并分析预后。明确影像学结外侵犯为总生存期较差的独立预后因素(读者1调整HR 1.72,P=.008;读者2调整HR 1.56,P=.03),但预测病理结外侵犯敏感度低(11%和23%)、特异度高(93%和87%)。

要点

  • 明确影像学结外侵犯与总生存期较差独立相关,可能/ probable结外侵犯则无独立预后价值。
  • 明确影像学结外侵犯预测病理结外侵犯敏感度低(11%/23%)、特异度高(93%/87%)。
  • 临床N2a病患者中,有无明确影像学结外侵犯的5年总生存率差异无统计学意义(P=.59和P=.49)。

核心结论

  • 影像学明确的结外侵犯是非小细胞肺癌患者总生存期较差的独立预测因素。
  • 影像学明确结外侵犯预测病理结外侵犯敏感度低但特异度高。

研究设计与样本

  • 回顾性研究纳入2010年1月至2016年12月诊断的非小细胞肺癌且临床N1或N2期患者382例(平均年龄67±10岁,男297例、女85例)。
  • 两位胸部放射科医师审阅分期胸部CT,记录影像学结外侵犯的主观总体印象(无、可能/ probable、明确),其中30例检查共识阅片、其余独立阅片。
  • 采用Kaplan-Meier生存分析和多因素Cox比例风险模型评估影像学结外侵犯预测总生存期的价值,并在临床N2a病患者中评估其预后价值。
  • 在203例接受手术的患者(66例有病理结外侵犯)中,确定影像学明确结外侵犯预测病理结外侵犯的敏感度和特异度。

诊断标准与关键数值

  • 影像学明确结外侵犯预测病理结外侵犯的敏感度和特异度:读者1为11%和93%,读者2为23%和87%(203例手术患者,66例有病理结外侵犯)。
  • 无、可能/ probable、明确影像学结外侵犯的5年总生存率:读者1为44.4%、39.1%、20.9%,读者2为45.7%、36.6%、25.6%。
  • 明确影像学结外侵犯为总生存期较差的独立预后因素:读者1调整HR 1.72(P=.008),读者2调整HR 1.56(P=.03);可能/ probable结外侵犯无独立预后价值:读者1调整HR 1.18(P=.33),读者2调整HR 1.21(P=.25)。

临床应用与阅片要点

  • 影像学明确结外侵犯可能用于非小细胞肺癌分期检查和治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Pathologic extranodal extension (ENE) in metastatic lymph nodes (LNs) has been associated with unfavorable prognosis in patients with non-small cell lung cancer (NSCLC). OBJECTIVE. The purpose of this article was to evaluate the prognostic utility of radiologic ENE and its diagnostic performance in predicting pathologic ENE in patients with NSCLC. METHODS. This retrospective study included 382 patients (mean age, 67 ± 10 [SD] years; 297 men, 85 women) diagnosed with NSCLC and clinical N1 or N2 disease between January 2010 and December 2016. Two thoracic radiologists reviewed staging chest CT examinations to record subjective overall impression for radiologic ENE (no ENE, possible/probable ENE, or unambiguous ENE), reviewing 30 examinations in consensus and the remaining examinations independently. Kaplan-Meier survival analysis and multivariable Cox proportional hazards model were used to evaluate the utility of radiologic ENE in predicting overall survival (OS). Prognostic utility of radiologic ENE was also assessed in patients with clinical N2a disease. In patients who underwent surgery, sensitivity and specificity were determined of radiologic unambiguous ENE in predicting pathologic ENE. RESULTS. The 5-year OS rates for no ENE, possible/probable ENE, and unambiguous ENE were 44.4%, 39.1%, and 20.9% for reader 1 and 45.7%, 36.6%, and 25.6% for reader 2, respectively. Unambiguous ENE was an independent prognostic factor for worse OS (reader 1: adjusted HR, 1.72, p = .008; reader 2: adjusted HR, 1.56, p = .03), whereas possible/probable ENE was not (reader 1: adjusted HR, 1.18, p = .33; reader 2: adjusted HR, 1.21, p = .25). In patients with clinical N2a disease, 5-year OS rate in patients with versus without unambiguous ENE for reader 1 was 22.2% versus 40.6% (p = .59) and for reader 2 was 27.6% versus 41.0% (p = .49). In 203 patients who underwent surgery (66 with pathologic ENE), sensitivity and specificity of radiologic unambiguous ENE for predicting pathologic ENE were 11% and 93% for reader 1 and 23% and 87% for reader 2. CONCLUSION. Radiologic unambiguous ENE was an independent predictor of worse OS in patients with NSCLC. The finding had low sensitivity but high specificity for pathologic ENE. CLINICAL IMPACT. Radiologic ENE may have a role in NSCLC staging workup and treatment selection.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Jang, Lee, Chung, et al. Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance. AJR Am J Roentgenol. 2023. PMID: 37255045. doi:10.2214/AJR.23.29285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。